8HD3
Farnesoid X Receptor Agonists_FXR fused with a HD3 peptide
Entity
| Entity ID | Chain ID | Description | Type | Chain length | Formula weight | Number of molecules | DB Name (Accession) | Biological source | Descriptive keywords |
| 1 | A, B (A, B) | Farnesoid X Receptor | polymer | 260 | 29968.2 | 2 | UniProt (Q96RI1) Pfam (PF00104) | Homo sapiens (human) | |
| 2 | C, D (A, B) | [(3s,5s,7s)-adamantan-1-yl][4-(2-amino-5-chlorophenyl)piperazin-1-yl]methanone | non-polymer | 373.9 | 2 | Chemie (XAW) | |||
| 3 | E, F (A, B) | water | water | 18.0 | 17 | Chemie (HOH) |
Sequence modifications
A, B: 257 - 485 (UniProt: Q96RI1)
| PDB | External Database | Details |
|---|---|---|
| Met 247 | - | initiating methionine |
| Gly 248 | - | expression tag |
| His 249 | - | expression tag |
| His 250 | - | expression tag |
| His 251 | - | expression tag |
| His 252 | - | expression tag |
| His 253 | - | expression tag |
| His 254 | - | expression tag |
| Gly 255 | - | expression tag |
| Ser 256 | - | expression tag |
| Ala 291 | Glu 291 | engineered mutation |
| Ala 364 | Glu 364 | engineered mutation |
| Gly 486 | - | expression tag |
| Ser 487 | - | expression tag |
| Gly 488 | - | expression tag |
| Ser 489 | - | expression tag |
| Gly 490 | - | expression tag |
| Ser 491 | - | expression tag |
| Gly 492 | - | expression tag |
| Ser 493 | - | expression tag |
| Gly 494 | - | expression tag |
| Asp 495 | - | expression tag |
| His 496 | - | expression tag |
| Gln 497 | - | expression tag |
| Leu 498 | - | expression tag |
| Leu 499 | - | expression tag |
| Arg 500 | - | expression tag |
| Tyr 501 | - | expression tag |
| Leu 502 | - | expression tag |
| Leu 503 | - | expression tag |
| Asp 504 | - | expression tag |
| Lys 505 | - | expression tag |
| Asp 506 | - | expression tag |
Sequence viewer
Contents of the asymmetric unit
| Polymers | Number of chains | 2 |
| Total formula weight | 59936.5 | |
| Non-Polymers* | Number of molecules | 2 |
| Total formula weight | 747.8 | |
| All* | Total formula weight | 60684.3 |






